Norberto Oggioni
Monza, 20900, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain.
Journal: Frontiers in pharmacology
Published: November 17, 2021
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity.
Journal: International journal of molecular sciences
Published: December 29, 2020
Reply to a Comment Paper on the Published Paper by Canta, A. et al: "Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity"-Antioxidants 2020, 9, 594.
Journal: Antioxidants (Basel, Switzerland)
Published: August 20, 2020
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity.
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity.
Journal: Experimental neurology
Published: July 10, 2020
Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity.
Journal: Antioxidants (Basel, Switzerland)
Published: June 01, 2020
Global Transcriptomic Profile of Dorsal Root Ganglion and Physiological Correlates of Cisplatin-Induced Peripheral Neuropathy.
Journal: Nursing research
Published: December 27, 2018
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats.
Journal: Journal of neuroinflammation
Published: May 30, 2018
Age-related changes in the function and structure of the peripheral sensory pathway in mice.
Journal: Neurobiology of aging
Published: April 01, 2016
Toward the identification of neuroprotective agents: g-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist.
Journal: Future medicinal chemistry
Published: February 23, 2016
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy.
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy.
Journal: Experimental neurology
Published: January 27, 2016
Last Updated: 09/26/2026